Skip to main content
. 2012 Dec 12;52(1):91–98. doi: 10.1093/rheumatology/kes350

Table 2.

Overall and solid cancer SIRs

Overall
Male
Female
Total follow-up, pyrs 13 315 3732 9584
Cancer site and ICD-10 code O Rate per 100 pyrs (95% CI) E SIR (95% CI) O Rate per 100 pyrs (95% CI) E SIR (95% CI) O Rate per 100 pyrs (95% CI) E SIR (95% CI)
All sites (ICD-10 C00–C97 × C44) 182 1.37 (1.18, 1.58) 141.80 1.281.10, 1.48 58 1.55 (1.18, 2.01) 51.92 1.11 (0.85, 1.44) 124 1.29 (1.08, 1.54) 89.88 1.38 (1.15, 1.64)
All sites—England only 168 1.50 (1.28, 1.75) 120.75 1.39 (1.19, 1.62) 55 1.70 (1.28, 2.21) 45.76 1.20 (0.91, 1.56) 113 1.42 (1.17, 1.71) 74.99 1.51 (1.24, 1.81)
Solid cancers C00–C80 × C44 156 1.17 (0.99, 1.37) 131.09 1.19 (1.01, 1.39) 49 1.31 (0.97, 1.74) 47.70 1.03 (0.76, 1.36) 107 1.12 (0.91, 1.35) 83.39 1.28 (1.05, 1.55)
Solid cancers England only 143 1.28 (1.08, 1.51) 111.50 1.28 (1.08, 1.51) 46 1.42 (1.04, 1.89) 42.04 1.09 (0.80, 1.46) 97 1.22 (0.99, 1.49) 69.56 1.39 (1.13, 1.70)
Oesophagus C15 5 0.04 (0.01, 0.19) 3.39 1.47 (0.48, 3.44) NR NR NR NR NR NR NR NR
Stomach C16 6 0.05 (0.02, 0.10) 3.20 1.88 (0.69, 4.09) NR NR NR NR NR NR NR NR
Colorectal C18–C20 17 0.13 (0.07, 0.20) 17.69 0.96 (0.56, 1.54) 7 0.19 (0.07, 0.39) 7.33 0.96 (0.38, 1.97) 10 0.10 (0.05, 0.19) 10.36 0.97 (0.46, 1.78)
Lung C34 46 0.35 (0.25, 0.46) 19.24 2.39 (1.75, 3.19) 16 0.43 (0.25, 0.70) 7.96 2.01 (1.15, 3.26) 30 0.31 (0.21, 0.45) 11.28 2.66 (1.79, 3.80)
Melanoma C43 9 0.07 (0.03, 0.13) 4.38 2.05 (0.94, 3.90) NR NR NR NR 6 0.06 (0.02, 0.14) 2.93 2.05 (0.75, 4.46)
Breast C50 30 0.31 (0.21, 0.45) 28.16 1.07 (0.72, 1.52)
Prostate C61 5 0.13 (0.04, 0.31) 14.22 0.35 (0.11, 0.82)
Female genital organs C51–C58 4 0.04 (0.01, 0.11) 11.35 0.35 (0.10, 0.90)

O: observed; E: expected; NR: not reported (fewer than five observed or expected cancers).